BioXcel starts mid-stage BXCL501 trial for treatment of delirium related agitation
February 25 2021 - 7:16AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Apr 2023 to Apr 2024